Microthrombotic/microangiopathic manifestations of the antiphospholipid syndrome

Sonja Praprotnik1, Dusan Ferluga, Alenka Vizjak

  • 1Clinical Department of Rheumatology, University Medical Center Ljubljana, Ljubljana, Slovenia.

Insights

This study reclassifies antiphospholipid syndrome (APS) histopathology, proposing new criteria for definite APS. It highlights microvascular thrombotic and microangiopathic lesions in APS, crucial for understanding microangiopathic antiphospholipid syndrome (MAPS).

Area of Science:

  • Pathology
  • Rheumatology
  • Hematology

Background:

  • Antiphospholipid syndrome (APS) classification lacks detailed histopathologic correlation.
  • Microvascular thrombotic and microangiopathic lesions are key in APS but require systematic study.

Purpose of the Study:

  • To propose a novel categorization of histopathologic lesions in APS.
  • To revise classification criteria for definite APS by including microangiopathic lesions.
  • To explore clinico-pathologic correlations in microangiopathic antiphospholipid syndrome (MAPS).

Main Methods:

  • Review of autopsy and biopsy studies in patients with APS.
  • Analysis of histopathologic findings in various organs.
  • Comparison of lesion types and ages in classic and catastrophic APS.

Main Results:

  • A novel categorization of histopathologic lesions in APS is proposed.
  • Inclusion of microangiopathic lesions in revised APS classification criteria is suggested.
  • Microvascular thrombotic and microangiopathic lesions coexist and vary in age in APS patients, supporting the MAPS concept.

Conclusions:

  • Histopathologic findings support the concept of microangiopathic antiphospholipid syndrome (MAPS).
  • Revised classification criteria for APS should incorporate microangiopathic lesions.
  • Endothelial cell affection and coagulation cascade interference are key pathogenic mechanisms in APS.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...